Publication: Immune-mediated hemolytic anemia in pediatric renal transplantation
Issued Date
2006-09-01
Resource Type
ISSN
13993046
13973142
13973142
Other identifier(s)
2-s2.0-33746907013
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pediatric Transplantation. Vol.10, No.6 (2006), 740-743
Suggested Citation
Anirut Pattaragarn, Vip Viprakasit, Suroj Supavekin, Achra Sumboonnanonda Immune-mediated hemolytic anemia in pediatric renal transplantation. Pediatric Transplantation. Vol.10, No.6 (2006), 740-743. doi:10.1111/j.1399-3046.2006.00560.x Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/23624
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Immune-mediated hemolytic anemia in pediatric renal transplantation
Other Contributor(s)
Abstract
The aim of the study was to demonstrate clinical course of the first reported cases of PLS in pediatric kidney transplantation and therapeutic outcome for such condition using a combination of high-dose corticosteroid and tacrolimus. We report a single case (a nine-year-old Thai boy) with end-stage kidney disease secondary to obstructive uropathy developed immune-mediated hemolytic anemia from the PLS at second week after a pre-emptive living-related kidney transplantation. The alloimmune hemolysis was a result of anti-B antibodies, derived from blood group O-donor lymphocytes. Using a combination of high-dose corticosteroid and a substitution of cyclosporin with tacrolimus, there was no further hemolysis although the anti-B antibodies remained detectable until the eighth week post-transplantation. An impairment of the graft function because of hemoglobinuria was resolved after the hemolysis was stopped. The alloimmune hemolysis caused by PLS in pediatric kidney transplantation could be controlled with a combination of high-dose corticosteroid and tacrolimus. © 2006 Blackwell Munksgaard.